FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2297486162> ?p ?o ?g. }

• W2297486162 endingPage "347" @default.
• W2297486162 startingPage "340" @default.
• W2297486162 abstract "Predictors for successful treatment are important for personalized medicine. Predictors for drug survival of biologics in psoriasis have been assessed, but not split for different biologics or for the reason of discontinuation.To compare long-term drug survival between the outpatient biologics adalimumab, etanercept and ustekinumab in patients with psoriasis, and to elucidate predictors for overall survival and drug discontinuation due to ineffectiveness and side-effects for each biologic separately.Ten years of data were extracted from the prospective, multicentre, long-term BioCAPTURE registry. Kaplan-Meier survival analyses and confounder-corrected multivariate Cox regression analysis for drug survival (MCR-DS) were performed to compare drug survival between biologics. To elucidate the predictors for different reasons of discontinuation for each biologic, univariate Cox regression analyses and multivariate Cox regression analyses for predictors (MCR-P) with backward selection were performed.In total, 526 treatment episodes - 186 adalimumab, 238 etanercept and 102 ustekinumab - were included covering 1333 treatment years. MCR-DS showed a significantly higher overall survival for ustekinumab compared with adalimumab and etanercept. MCR-P showed that higher body mass index (BMI) was a predictor for discontinuation due to ineffectiveness for etanercept and ustekinumab and that female sex was a predictor for discontinuation due to side-effects for adalimumab, etanercept and ustekinumab.Ustekinumab has the highest confounder-corrected long-term drug survival in psoriasis treatment, compared with adalimumab and etanercept. Higher BMI is a predictor for discontinuation due to ineffectiveness in etanercept and ustekinumab, and female sex is a consistent predictor for discontinuation due to side-effects in all three outpatient biologics." @default.
• W2297486162 created "2016-06-24" @default.
• W2297486162 creator A5000467702 @default.
• W2297486162 creator A5002663215 @default.
• W2297486162 creator A5008080578 @default.
• W2297486162 creator A5016712561 @default.
• W2297486162 creator A5017085497 @default.
• W2297486162 creator A5017213436 @default.
• W2297486162 creator A5040557009 @default.
• W2297486162 creator A5044485746 @default.
• W2297486162 creator A5063960641 @default.
• W2297486162 creator A5064403166 @default.
• W2297486162 creator A5067187785 @default.
• W2297486162 creator A5074894108 @default.
• W2297486162 creator A5075304989 @default.
• W2297486162 creator A5081468793 @default.
• W2297486162 creator A5082636128 @default.
• W2297486162 creator A5090573967 @default.
• W2297486162 date "2016-06-25" @default.
• W2297486162 modified "2023-09-26" @default.
• W2297486162 title "Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t" @default.
• W2297486162 cites W1561480154 @default.
• W2297486162 cites W1597607780 @default.
• W2297486162 cites W1692288477 @default.
• W2297486162 cites W1922692046 @default.
• W2297486162 cites W1949675032 @default.
• W2297486162 cites W1966314202 @default.
• W2297486162 cites W1973064602 @default.
• W2297486162 cites W1975091847 @default.
• W2297486162 cites W1981133588 @default.
• W2297486162 cites W2010827973 @default.
• W2297486162 cites W2011009038 @default.
• W2297486162 cites W2033988686 @default.
• W2297486162 cites W2038277119 @default.
• W2297486162 cites W2040737548 @default.
• W2297486162 cites W2047252573 @default.
• W2297486162 cites W2053642683 @default.
• W2297486162 cites W2062730908 @default.
• W2297486162 cites W2065466502 @default.
• W2297486162 cites W2069350424 @default.
• W2297486162 cites W2073797451 @default.
• W2297486162 cites W2079603394 @default.
• W2297486162 cites W2080998405 @default.
• W2297486162 cites W2085074082 @default.
• W2297486162 cites W2096820688 @default.
• W2297486162 cites W2097896724 @default.
• W2297486162 cites W2098286250 @default.
• W2297486162 cites W2102823903 @default.
• W2297486162 cites W2109633277 @default.
• W2297486162 cites W2127958542 @default.
• W2297486162 cites W2145492843 @default.
• W2297486162 cites W2318799791 @default.
• W2297486162 doi "https://doi.org/10.1111/bjd.14552" @default.
• W2297486162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26989852" @default.
• W2297486162 hasPublicationYear "2016" @default.
• W2297486162 type Work @default.
• W2297486162 sameAs 2297486162 @default.
• W2297486162 citedByCount "61" @default.
• W2297486162 countsByYear W22974861622016 @default.
• W2297486162 countsByYear W22974861622017 @default.
• W2297486162 countsByYear W22974861622018 @default.
• W2297486162 countsByYear W22974861622019 @default.
• W2297486162 countsByYear W22974861622020 @default.
• W2297486162 countsByYear W22974861622021 @default.
• W2297486162 countsByYear W22974861622022 @default.
• W2297486162 countsByYear W22974861622023 @default.
• W2297486162 crossrefType "journal-article" @default.
• W2297486162 hasAuthorship W2297486162A5000467702 @default.
• W2297486162 hasAuthorship W2297486162A5002663215 @default.
• W2297486162 hasAuthorship W2297486162A5008080578 @default.
• W2297486162 hasAuthorship W2297486162A5016712561 @default.
• W2297486162 hasAuthorship W2297486162A5017085497 @default.
• W2297486162 hasAuthorship W2297486162A5017213436 @default.
• W2297486162 hasAuthorship W2297486162A5040557009 @default.
• W2297486162 hasAuthorship W2297486162A5044485746 @default.
• W2297486162 hasAuthorship W2297486162A5063960641 @default.
• W2297486162 hasAuthorship W2297486162A5064403166 @default.
• W2297486162 hasAuthorship W2297486162A5067187785 @default.
• W2297486162 hasAuthorship W2297486162A5074894108 @default.
• W2297486162 hasAuthorship W2297486162A5075304989 @default.
• W2297486162 hasAuthorship W2297486162A5081468793 @default.
• W2297486162 hasAuthorship W2297486162A5082636128 @default.
• W2297486162 hasAuthorship W2297486162A5090573967 @default.
• W2297486162 hasConcept C126322002 @default.
• W2297486162 hasConcept C16005928 @default.
• W2297486162 hasConcept C2777011040 @default.
• W2297486162 hasConcept C2777226972 @default.
• W2297486162 hasConcept C2777575956 @default.
• W2297486162 hasConcept C2778715236 @default.
• W2297486162 hasConcept C2778975655 @default.
• W2297486162 hasConcept C2779134260 @default.
• W2297486162 hasConcept C2780132546 @default.
• W2297486162 hasConcept C2780221984 @default.
• W2297486162 hasConcept C2780564577 @default.
• W2297486162 hasConcept C50382708 @default.
• W2297486162 hasConcept C71924100 @default.
• W2297486162 hasConceptScore W2297486162C126322002 @default.
• W2297486162 hasConceptScore W2297486162C16005928 @default.

• next